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Abstract
Background: The animal efficacy rule addressing development of drugs for selected disease categories has pointed out the
need to develop alternative large animal models. Based on this rule, the pathophysiology of the disease in the animal model
must be well characterized and must reflect that in humans. So far, manifestations of the acute radiation syndrome (ARS)
have been extensively studied only in two large animal models, the non-human primate (NHP) and the canine. We are
evaluating the suitability of the minipig as an additional large animal model for development of radiation countermeasures.
We have previously shown that the Gottingen minipig manifests hematopoietic ARS phases and symptoms similar to those
observed in canines, NHPs, and humans.
Principal Findings: We establish here the LD50/30 dose (radiation dose at which 50% of the animals succumb within 30
days), and show that at this dose the time of nadir and the duration of cytopenia resemble those observed for NHP and
canines, and mimic closely the kinetics of blood cell depletion and recovery in human patients with reversible
hematopoietic damage (H3 category, METREPOL approach). No signs of GI damage in terms of diarrhea or shortening of villi
were observed at doses up to 1.9 Gy. Platelet counts at days 10 and 14, number of days to reach critical platelet values,
duration of thrombocytopenia, neutrophil stress response at 3 hours and count at 14 days, and CRP-to-platelet ratio were
correlated with survival. The ratios between neutrophils, lymphocytes and platelets were significantly correlated with
exposure to irradiation at different time intervals.
Significance: As a non-rodent animal model, the minipig offers a useful alternative to NHP and canines, with attractive
features including ARS resembling human ARS, cost, and regulatory acceptability. Use of the minipig may allow accelerated
development of radiation countermeasures.
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Introduction
Use of nuclear energy for civilian and military application as
well as exploitation of radiological materials for criminal intents
pose risks to public health. The most recent example is the
accident at the Fukushima power plant in Japan, which triggered a
wide appreciation of the inadequacy of currently available
countermeasures to face such emergencies. A full understanding
of the pathophysiology of the acute radiation syndrome (ARS) is
still incomplete; drug development is lagging behind. To facilitate
approval of new drugs for selected conditions such as ARS, where
human efficacy studies are neither ethical nor feasible, the FDA
issued a draft guidance document (Animal Models - Essential
Elements to Address Efficacy Under the Animal Rule) to allow
consideration for marketing approval based on animal efficacy
studies, provided the product is demonstrated safe in humans. Still,
the shortage of suitable species for assessment of radiation
exposure and understanding of radiation sickness is hampering
research efforts, as the only well-characterized large animal models
for ARS are non-human primates and canines. Swine provide a
promising alternative to non-human primates and canines for
advanced drug screening [1], and may represent a better model to
study radiation damage to selected organs such as skin, kidneys
and lungs [2]. Swine display a marked similarity in anatomy and
physiology to human organs, and Gottingen minipigs are
maintained with a controlled genetic and microbiological
background. The cost is relatively low, and handling/husbandry
and sampling/dosing procedures are straightforward.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25210We have previously shown that the irradiated Gottingen minipig
is suitable for multiple large volume sampling for extended periods
of time (60 days) following irradiation [3] and that, at doses
bracketing the hematopoietic syndrome, it exhibits disease stages
characteristic of ARS in humans and other large animal models.
Moribund animals displayed signs of systemic inflammation and
multi-organ dysfunction, including widespread internal hemorrhag-
es and alteration in organ function reflected in blood chemistry;
sepsis was present in a minority of the animals. The sequence of
blood element declines followed the expected pattern, and bone
marrow aplasia was confirmed by histological observations [4].
In the current study, we addressed more precisely the question of
how the minipig compares to humans, NHP (non-human primates)
and dogs in terms of hematological changes. Hematological changes
(occurrence and duration of cytopenias, nadirs and onset of
hematopoietic recovery) at the LD50/30 (radiation dose at which
50% of the animals succumb within 30 days) have been used in
radiation biology for the past several years as a classic parameter of
comparison among species; more recently, several diagnostic and
prognostic indicators of ARS have been suggested in humans and
NHP based on hematological values and serum biomarkers. Among
these, the neutrophil-to-lymphocyteratio and C-reactive protein have
gained particular importance [5]. We determined the LD50/30 for
the Gottingen minipig using 5 radiation doses (whole body gamma,
0.6 Gy/min) and 6 animals per dose, characterized the dynamics of
platelet and neutrophil changes, and evaluated blood cell count- and
CRP-based parameters as prognostic/diagnostic indicators of ARS in
the Gottingen minipig. Our findings suggest that the pathophysiology
of hematopoietic ARS in the Gottingen minipig is very similar to that
observed in humans, NHPs and dogs. Although the LD50/30 in the
minipig was lower and the survival curve steeper as compared to
previous studies and to other models (4, 14–16), survival at specific
doses has been quite reproducible over several years. Additional
studies are underway to extend the survival curve to higher radiation
doses, and to determine the responsiveness of the irradiated minipig
to standard cytokine treatment.
Materials and Methods
Animal model and blood sampling
30 male Gottingen minipigs (4–5 months old, 9–11 kg) were
purchased from Marshall Bioresources (North Rose, NY). Proce-
dureswereperformedinaccordance withprotocolsapprovedbythe
Armed Forces Radiobiology Research Institute (AFRRI) Institu-
tional Animal Care and Use Committee. AFRRI is fully accredited
by the Association for Assessment and Accreditation of Laboratory
Animal Care, International. The protocol was approved by the
Armed Forces Radiobiology Research Institute IACUC Commit-
tee. Animals received appropriate environmental enrichment, and
all efforts were made to minimize suffering [3]. The first blood
sample was taken 6 days prior to VAP implantation via the cranial
vena cava. The day of irradiation (3 weeks after VAP surgery) was
considered day 0. Additional blood samples were collected on days
214, 27a n d21, at +3h ,+7h ,+11 h, +27 h, +31 h and +35 h,
and on days +2, +3, +7, +10, +14, +17, +20, +24, +27, +30 and, for
selected cases, +60, depending upon survival.
Blood counts
Blood was collected in EDTA tubes and immediately processed
for complete blood counts with differentials (CBC/diffs) using the
ADVIA 2120 (Siemens Medical Solutions Diagnostics, Ireland).
The remaining plasma was aliquoted and stored at 280uC for
further analysis. At the end of the study, animals were anesthetized
with tiletamine/zolazepam (TelazolH, 6–8 mg/kg IM) and
humanely euthanized with an intravenous overdose of sodium
pentobarbital (EuthasolH), according to current American Veter-
inary Medical Association (AVMA) guidelines. A full necropsy was
performed in all cases and histopathological examination (Hema-
toxylin and Eosin (H&E)) of all tissues was conducted.
Irradiation procedure and dosimetry
Prior to irradiation, animals were anesthetized with tiletamine/
zolazepam (TelazolH, 6–8 mg/kg IM) and administered a bolus
injection of atropine (0.05 mg/kg IM) to decrease salivary
secretions. Minipigs were irradiated bilaterally in a sling in the
AFRRI Co-60 facility with 1.6, 1.7, 1.8, 1.9 or 2 Gy, at the dose
rate 0.5–0.6 Gy/min, as described elsewhere [4].
C-reactive protein
Concentrations of C-reactive protein (CRP) in blood plasma
samples were assessed using a commercially-available porcine-
Figure 1. Dose response curves for bilateral gamma-irradiation
of Gottingen minipig. Six animals per dose were irradiated with
Cobalt-60 (0.6 Gy/min). Survival was followed for 30 days after exposure
and data were plotted as Kaplan-Meier curves (Panel A). Probit analysis
was used to fit survival curves and calculate dose-response (Panel B)
and confidence intervals (Panel C).
doi:10.1371/journal.pone.0025210.g001
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the manufacturer’s instructions. Detection limits were 6.25–
200 ng/mL. Single-use plasma aliquots stored at 280uC were
thawed on ice, diluted 1:2000 and measured in duplicate. Samples
were measured using a plate reader (SpectraMax M5, Molecular
Devices, CA, USA) set at an absorbance of 450 nm.
Statistical analysis
Basic descriptive analysis and two-sided Student’s t-tests were
done in Excel. Spearman Rank correlation was calculated using
the Free Statistics and Forecasting Software Calculator at: http://
www.wessa.net/rankcorr.wasp. Probit regression analysis was used
to generate the probit curve, using the PASW Statistic 18 software,
SPSS Inc, IL, USA. Survival curves were plotted using the
Kaplan-Meier method.
Results and Discussion
Hematological and histological changes at the LD50/30
Comparison between Gottingen minipigs, humans and
other large animal models. We are studying the effect of
acute radiation in the Gottingen minipig to evaluate whether this
model is suitable for rapid development of advanced
countermeasures, as a complement to the existing large animal
models for the ARS, the NHPs and canines. Comparison of lethal
responses in different species under various conditions of
irradiation has been achieved, over the years, through
evaluation of hematological values at the hematopoietic LD50
dose, the radiation dose that results in 50% of lethality (LD50).
We established the LD50/30 in the Gottingen minipig using 5
doses (total body irradiation, TBI, bilateral, Co-60, 0.6 Gy/min)
and 6 animals per dose, and monitored hematological changes
over 30–60 days. All animals either succumbed by 30 days, or
were showing clear signs of hematological recovery before 30 days
(see below). Baseline hematology data were obtained from 4 sham-
irradiated animals, subjected to the same treatment and sampling
schedule as the irradiated ones. From our study, the LD50/30 for
the Gottingen minipig was 1.73 Gy, (Cobalt-60, 0.6 Gy/min,
TBI, bilateral) (Figure 1), in agreement with the 1.7–3.7 Gy range
for LD50/30s previously reported for swine, including domestic
swine and minipigs [6–8]. This value corresponds to about half the
value of humans (accepted estimated value 3–4 Gy with no
Figure 2. Ranges (min, max) of blood cell loss and recovery in irradiated minipigs. Graphs represent the minimum and maximum blood
cell values observed over time from 30 animals irradiated with doses ranging from 1.6 to 2.0 Gy at 0.1 Gy dose intervals and pooled together (6
animals/dose).
doi:10.1371/journal.pone.0025210.g002
Table 1. Platelet and neutrophil nadirs and duration of cytopenias of irradiated minipigs.
Survival Thrombocytopenia (plt,20/nL) Neutropenia (ANC,0.5/nL) % cytopenic
Dose % median nadir duration nadir duration animals
(Gy) day day plt/nL weeks day ANC/nL weeks
1.6 0.8 30 17 4.5 .1 20 0.21 ,18 3 %
(29–30) (14–23) (2–10) (17–20) (0.12–0.39)
1.7 0.7 30 14 3.5 .1–2 17 0.16 .11 0 0 %
(14–30) (14–17) (1–17) (14–23) (0.09–0.46)
1.8 0.3 21 14 2.5 .2 17 0.13 .21 0 0 %
(16–30) (14–20) (1–9) (17–17) (0.03–0.31)
1.9 0.0 21.5 14 2.5 no recovery 17 0.04 no recovery 100%
(14–27) (14–17) (1–4) (14–20) (0.03–0.17)
2.0 0.0 18 14 3 no recovery 15.5 0.07 no recovery 100%
(14–20) (14–17) (1–9) (14–20) (0.04–0.28)
Range values (min, max) are reported in parenthesis; plt: platelets; ANC: absolute neutrophil number.
doi:10.1371/journal.pone.0025210.t001
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humans. The relative radiosensitivity of the Gottingen minipig
raises questions concerning the possibility of genetic mutations,
defects in DNA repair, the effects of inbreeding, etc. In terms of
mutations, the proportional dwarfism characteristic of the
Gottingen minipig, referred to as ‘‘pituitary dwarfism’’, is found
in a number of farm animal breeds, i.e. Dexter cattle, Shetland
pony and, unlike the ‘‘achondroplasia’’ type of dwarfism, is a
genetically fixed trait and not considered a genetic defect [10
Simianer]. Deficiency in DNA repair mechanisms does not seem
to explain the radiosensitivity in the Gottingen minipig, since
DNA double-strand break repair kinetics in blood cells, based on
gammaH2AX focus expression, have been found to be similar to
that of in humans and NHPs (C. Redon, personal communica-
tion). Inbreeding for this strain is controlled and kept under 10%
[10–11]. Mapping of the minipig genome is ongoing [12], and
may provide some insight into this issue which for the moment
remains unresolved.
Although the LD50/30 was significantly lower than that of
humans, hematological changes in the minipig (Figure 2) were very
similar to what has been observed in victims of criticality accidents.
We considered the METREPOL hematology category H3
(autologous recovery certain with high risk critical phase) [13] as a
reasonable representation of the pathophysiology of humans at the
LD50/30. In patients with the H3 level of hematopoietic effect, the
hematopoietic depression resulted in rapid loss of lymphocytes,
reaching minimum values within 2 days. Disappearance of
granulocytes from peripheral blood started to occur within 2–4
days, and was preceded by an initial granulocytosis during the first
two days after exposure, due to mobilization from marrow and
possibly spleen storage pools. An abortive rise could be noted
starting around day 5 and neutropenia (,0.5610
3 cells/ml) was
reached around days 10–15. The platelet decline was steady and
relatively slow; thrombocytopenia (,20610
3cells/ml) was reached
by 2–3 weeks. Nadirs for neutrophils and platelets were reached
around 3–4 weeks; the duration of cytopenias was approximately 20
days. Recovery began 5–6 weeks post-exposure with platelets
returning to normal values after approximately 8 weeks [13]. Very
similardynamicswereobservedfortheGottingenminipig(Figure2),
witha rapiddecline inlymphocyte countswithin48 hours,an initial
stress response of granulocytes followed by a decline and abortive
rise before reaching neutropenic levels by 14–17 days, and slow loss
of platelets following an initial shoulder, with thrombocytopenic
levels reached by 10–14 days. At doses close to the LD50/30
(Table 1), nadirs for platelets and neutrophils were reached around
days 14–17 and 14–23, respectively. The duration for both
thrombocytopenia and neutropenia was around 1–2 weeks, and
recovery started around 3–4 weeks after exposure (Table 2). Full
recovery of platelets required more than 8 weeks. Only eight
animals out of 30 showed signs of anemia (hematocrit range 6%–
13%; median 11.6%). Anemia is not considered a survival-limiting
factor in humans, but increases in importance in NHP, dogs and
guinea-pigs and is most important in mice and rats [14].
For the comparison of hematological dynamics in the irradiated
minipig with other large animal models (Table 2), we referred to
published studies that used radiation doses close to the accepted
LD50/30 values for NHP (6.5 Gy) [14,15] and dogs (2.6 Gy) [16].
In the Beagle dog irradiated with 3 Gy (Co-60, 10 cGy/min,
TBI), nadirs were reached around days 14–17 (neutrophils) and 20
(platelets) [17,18]. Neutropenia and thrombocytopenia lasted for
about 2 to 3 weeks. For Rhesus monkeys irradiated with 7 Gy,
nadirs for platelet and neutrophil counts were reached around 12–
15 days and recovery started 2–3 days later. Neutrophil and
platelet counts returned to almost normal values after approxi-
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obtained in the Gottingen minipig.
The similarities in rate of hematopoietic changes between swine
and humans, consistent with NHP and canines, support the
suitability of the minipig as a model for the hematopoietic syndrome
of ARS. During steady-state production, the mean value for
myelocyte-to-blood transit time is 8–10 days for human [13], 6–7
days in swine, and 4–6 days for dogs [21]. Neutrophil half lives in
circulation are comparable in all these species, about 6.6 hours for
man, 8 hours for swine [22], and 7 hours for dogs [23]. As for
platelets, total transit time from the appearance of the most
immature megakaryocyte in the marrow to the release of platelets in
the human peripheral blood is 8–10 days, and the life span is 8–10
days [13]; total megakaryocyte maturation time in pigs ranges from
about 5 to 10 days and life span of platelets is 5–7 days [24]; in dogs,
the platelet life span is 9 days [25]; and in Rhesus monkey the life
span is about 6.5 days [26]. The lifespan of RBC is around 80–100
days in the swine [27], 100–115 in the dog [27], 85 days in Rhesus
monkey [28] and 120 days in humans [13].
Unlike dogs, where diarrhea, bloody feces, and ulceration in the
cecum/colon/rectum occurred already at the LD50/30 [16], in the
Gottingen minipig widespread hemorrhages were present, but no
signs of diarrhea or necrosis/ulceration were observed up to 1.9 Gy.
Histopathological examination indicated that in duodenum, jejunum
and ileum, villar length, epithelial morphology, crypt numbers and
morphology were within normal limits through radiation doses of
1.9 Gy (Figure 3a and Figure 3b). Animals dosed at 2.0 Gy began to
show signs of regeneration after denudation of the villi, presumably
secondary to radiation injury. This consisted primarily of blunting
and fusion in which multiple denuded villi fused together and a single
regenerative layer of epithelium stretched to cover all affected villi
(Figure 3c). Crypts were consistent in overall number with those in
animals undergoing lesser radiation doses; however, the crypt
epithelium underwent mild morphological changes comprising
increased piling of the epithelial cells and occasional crypt dysplasia
comprised of elongated tortuous and branching crypts, especially
subjacent to the blunted and fused villi. Histopathological changes in
the large intestine consisted of varying degrees of mucosal and
submucosal hemorrhage with no radiation-associated alterations of
the mucosal epithelium.
Prognostic and diagnostic indicators. To further assess
similarities between the Gottingen minipig and humans and
Figure 3. Histological examination of crypts and villi in the duodenum of irradiated minipigs (1.6 to 2.0 Gy). Samples were collected
and fixed at necropsy. Panel A (1.6 Gy, H&E 1006). Villar length is consistent throughout the section, and is of normal length, lined by a single layer of
columnar epithelium with basilar nuclei and abundant eosinophilic apical cytoplasm. Underlying crypts are densely packed. Panel B (1.9 Gy, H&E
1006). Villar length remains consisted in length and in morphology of the overlying epithelium as well as the abundance and morphology of the
underlying villar crypts. Panel C (2.0 Gy, H&E 2006). Multifocally throughout the section, villi are blunted and fused (asterix) with multiple villi
recovering by denudation by being covered by a single layer of columnar epithelium. Underlying crypts (arrows) have piled epithelium and
occasionally are tortuous; however there is no apparent loss of crypts.
doi:10.1371/journal.pone.0025210.g003
Table 3. Spearman rank correlation (r) of platelet counts-based parameters with survival in irradiated G. minipig (n=30).
Counts/nL Counts/nL Counts/nL
Days to
reach Days to reach
Days to
reach No. of days with
Survived at 7 day at 10 day at 14 day 300 plt/nL 20 plt/nL nadir ,20 plt/nL
median 304 53.5 6 7 12 17 1.5
min 110 20 3 4 10 14 0
max 344 134 30 8 17 23 4
Not-survived
median 188 18 3 5 9.5 14 4
min 119 3 1 3 9 10 2
max 278 55 7 6 11 17 4
r 0.49 0.627 0.64 0.6 0.62 0.61 20.66
p value 0.049 0.0006 0.0002 0.001 0.0008 0.0009 0.0001
Plt: platelets; p value (Student’s T-test).
doi:10.1371/journal.pone.0025210.t003
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prognostic indicators related to the dynamics of blood element
declines. In irradiated humans [29], platelet counts and number of
days to reach critical values for granulocytes and thrombocytes
were found associated with ARS grades [30]. We previously
showed that in the Gottingen minipig, platelet cut-off values could
be used to predict mortality [4]; in the current study (30 animals),
we measured the Spearman rank correlation coefficient (r)
between 30 day survival (or less than 30 day survival) and (i)
absolute platelet counts (at days 10, when the prodromal phase
starts to taper off, and 14, when the first deaths occur); (ii) number
of days to reach critical platelet values i.e. minimum normal levels
(300,000/mL), thrombocytopenic levels (,20,000/mL) and nadir;
(iii) number of days of thrombocytopenia until the first death (day
14). All these parameters were found significantly associated with
survival (Table 3). Also, (iv) neutrophil counts at 14 days as well as
(v) neutrophil relative increases over pre-irradiation values at
3 hours after irradiation were significantly associated with survival
(Table 4), again reinforcing the similarities in pathophysiology of
the ARS between swine and human [30,31]. In agreement with
the NHP data of Stickney et al [20], we found that in the
Gottingen minipig the cumulative number of days of
thrombocytopenia (rs 20.66) but not (vi) neutropenia (rs 20.19)
was significantly associated with outcome. Recently, we have
shown that in minipigs C-reactive protein (CRP), an acute phase
protein found increased in irradiated victims and proposed as a
biomarker of irradiation [5], significantly increased after
irradiation, and that at $14 days post-radiation elevated CRP
levels were correlated with prognosis [4]. Here, we measured the
ratio between CRP and platelet counts (vii); a highly significant
negative association with survival was found starting at day 10
(rs=2.65, p#0.001), more so than CRP values alone; a
statistically significant difference between 14 day CRP levels in
surviving versus non-surviving animals was confirmed in the
current study (p,0.05).
In terms of diagnostic indicators, rapid assessment of exposure is
important to provide the best medical care and optimize the use of
resources. In addition to the abundance of proposed indicators of
exposure, hematological responses can provide simple and reliable
early indicators. Lymphocyte drops and hematological changes
Figure 4. Ratio of hematological parameters. Neutrophil-to-lymphocyte (A), neutrophil-to-platelet (B), and platelet-to-lymphocyte (C) ratios
were calculated for sham-irradiated animals (diamonds, n=4) and for animals irradiated with 1.6–2.0 Gy (squares, n=30). Ratios were calculated for
each individual animal and results were pooled together. Asterisks (*) indicate statistically significant difference between groups (Student T-test); bars
represent standard errors.
doi:10.1371/journal.pone.0025210.g004
Table 4. Spearman rank correlation (r) of ANC counts- and CRP-based parameters with survival in irradiated G. minipig (n=30).
Survived ANC Counts/mL ANC relative increase No. of days CRP:plt
at 14 day at 3 hr ,0.5 ANC/mL 10 day 14 day
median 0.9 1.58 0 0.3 2.6
min 0.4 1 0 0.1 0.4
max 2.7 3.4 1 1.1 7.1
Not-survived
median 0.335 2.75 0 1.2 9.7
min 0 1.2 0 0.3 2
max 1.1 10 3 8.5 68
r 0.569 –0.58 –0.19 –0.65 –0.61
p value 0.002 0.001 ,0.001 0.001
ANC: absolute neutrophil counts; CRP: C-reactive protein; CRP:plt : CRP-to-platelets ratio; p value (Students’ T-test).
doi:10.1371/journal.pone.0025210.t004
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estimates and for criticality accidents [29,32]. In the minipig a
rapid decline of lymphocyte counts was observed over the first
12 hours, which is indicative of severe exposure to radiation
according to Goans and colleagues (op. cit.). Accordingly, the
neutrophil-to-lymphocyte ratio, a recently developed diagnostic
indicator considered more practical than lymphocyte count alone
in humans and NHPs [5], clearly separated irradiated versus non-
irradiated animals at 3 hours and up to 10 days after exposure
(Figure 4). Along the same line, we determined the neutrophil-to-
platelet and the platelet-to-lymphocyte ratios in un-irradiated
versus irradiated animals. Both those ratios were significantly
different between the two groups up to 30 days after exposure; for
the platelet-to-lymphocyte ratio, the extent of the difference was
about 100-fold larger than observed for the neutrophil-to-
lymphocyte ratio, and covered a time window from 3 hours to
30 days (Figure 4), thus making this index more sensitive than the
neutrophil-to-lymphocyte ratio.
We conclude that the pathophysiology of ARS in the Gottingen
minipig is similar to that observed in humans, NHP, and dogs in
terms of hematological dynamics and importance of thrombocyte
counts. The Gottingen minipig appears to be a suitable alternative
large animal model to study the radiation-induced hematopoietic
syndrome and to test radiation countermeasures. Additional
experiments to characterize other aspects of ARS in Gottingen
minipigs are ongoing.
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